tiprankstipranks
Amplia Therapeutics Ltd. (AU:ATX)
ASX:ATX
Australian Market
ATX
Amplia Therapeutics
RESEARCH TOOLSreports
Want to see AU:ATX full AI Analyst Report?

Amplia Therapeutics (ATX) Financial Statements

24 Followers

Amplia Therapeutics Financial Overview

Amplia Therapeutics's market cap is currently AU$61.60M. The company's EPS TTM is AU$-0.0169; its P/E ratio is -7.66; Amplia Therapeutics is scheduled to report earnings on May 29, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueAU$ 0.00AU$ 3.78MAU$ 4.45MAU$ 1.19MAU$ 1.98M
Gross ProfitAU$ -92.14KAU$ 3.57MAU$ 4.01MAU$ 1.12MAU$ 1.98M
Operating IncomeAU$ -13.18MAU$ -6.52MAU$ -4.42MAU$ -7.48MAU$ -3.64M
EBITDAAU$ -13.09MAU$ -6.78MAU$ -4.48MAU$ -7.26MAU$ -3.64M
Net IncomeAU$ -7.71MAU$ -6.57MAU$ -4.50MAU$ -6.24MAU$ -3.64M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 27.85MAU$ 10.86MAU$ 3.39MAU$ 9.26MAU$ 14.61M
Total AssetsAU$ 41.44MAU$ 22.94MAU$ 14.85MAU$ 18.68MAU$ 24.48M
Total DebtAU$ 341.11KAU$ 13.89KAU$ 1.59MAU$ 2.27MAU$ 2.10M
Net DebtAU$ -27.51MAU$ -10.85MAU$ -1.80MAU$ -6.99MAU$ -12.51M
Total LiabilitiesAU$ 1.97MAU$ 1.91MAU$ 3.43MAU$ 2.85MAU$ 2.64M
Stockholders' EquityAU$ 39.47MAU$ 21.02MAU$ 11.42MAU$ 15.84MAU$ 21.85M
Cash Flow
Free Cash FlowAU$ -8.77MAU$ -6.89MAU$ -5.13MAU$ -5.31MAU$ -4.42M
Operating Cash FlowAU$ -8.73MAU$ -6.89MAU$ -5.13MAU$ -5.29MAU$ -4.40M
Investing Cash FlowAU$ -96.22KAU$ -2.07KAU$ -2.23KAU$ -58.42KAU$ -26.64K
Financing Cash FlowAU$ 25.94MAU$ 14.32MAU$ -772.98KAU$ -84.22KAU$ 17.19M
Currency in AUD

Amplia Therapeutics Earnings and Revenue History

Income Statement >

Amplia Therapeutics Debt to Assets

Balance Sheet >

Amplia Therapeutics Cash Flow

Cash Flow >

Amplia Therapeutics Forecast EPS vs Actual EPS

Earnings >